1. Stocks
  2. Lantern Pharma Inc
  3. Swot
swot-logo

Lantern Pharma Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Lantern Pharma Inc has 15 Strengths, 7 Weaknesses, 1 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over the Quarter (3 Months)

Stocks whose current price is 20% higher than week low, and more than previous close

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Companies with Low Debt

Stock gained more than 20% in one month

Top Gainers

Stock with Low PE (PE < = 10)

RSI indicating price strength

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Low Piotroski Score : Companies with weak financials

Annual net profit declining for last 2 years

Book Value Per Share deteriorating for last 2 years

MFs increased their shareholding last quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks